Product Code Database
Example Keywords: linux -playstation $31
barcode-scavenger
   » » Wiki: Giant Cell Arteritis
Tag Wiki 'Giant Cell Arteritis'.
Tag

Giant cell arteritis ( GCA), also called temporal arteritis, is an autoimmune disease of large . Symptoms may include , pain over the temples, flu-like symptoms, , and difficulty opening the mouth. Complications can include blockage of the artery to the eye with resulting , as well as aortic dissection, and . GCA is frequently associated with polymyalgia rheumatica.

The cause is unknown. The underlying mechanism involves inflammation of the that supply the walls of larger arteries. This mainly affects arteries around the head and neck, though some in the chest may also be affected. Diagnosis is suspected based on symptoms, blood tests, and , and confirmed by of the temporal artery. However, in about 10% of people the temporal artery is normal.

Treatment is typical with high doses of such as or . Once symptoms have resolved, the dose is decreased by about 15% per month. Once a low dose is reached, the taper is slowed further over the subsequent year. Other medications that may be recommended include to prevent bone loss and a proton-pump inhibitor to prevent stomach problems.

It affects about 1 in 15,000 people over the age of 50 per year. The condition mostly occurs in those over the age of 50, being most common among those in their 70s. Females are more often affected than males. Those of northern European descent are more commonly affected.

(2025). 9780323242875, Elsevier Health Sciences. .
is typically normal. The first description of the condition occurred in 1890.
(2025). 9780128032688, Academic Press. .


Signs and symptoms
Common symptoms of giant cell arteritis include:

The inflammation may affect blood supply to the ; blurred vision or sudden may occur. In 76% of cases involving the eye, the ophthalmic artery is involved, causing arteritic anterior ischemic optic neuropathy.

Giant cell arteritis may present with atypical or overlapping features. Early and accurate diagnosis is important to prevent ischemic vision loss. Therefore, this condition is considered a medical emergency.

While studies vary as to the exact rate of giant cell arteritis, relapse of this condition can occur. It most often happens at low doses of prednisone (<20 mg/day), during the first year of treatment, and the most common signs of relapse are headache and polymyalgia rheumatica.


Associated conditions
The varicella-zoster virus (VZV) was found in 74% of temporal artery biopsies that were GCA-positive, suggesting that the VZV infection may trigger the inflammatory cascade.

The disorder may co-exist (in about half of cases) with polymyalgia rheumatica (PMR), which is characterized by sudden onset of pain and stiffness in muscles (, ) of the body and is seen in the elderly. GCA and PMR are so closely linked that they are often considered to be different manifestations of the same disease process. PMR usually lacks the symptoms, including headache, pain in the jaw while chewing, and vision symptoms, that are present in GCA.

Giant cell arteritis can affect the aorta and lead to and aortic dissection. Up to 67% of people with GCA having evidence of an inflamed aorta, which can increase the risk of aortic aneurysm and dissection. There are arguments for the routine screening of each person with GCA for this possible life-threatening complication by imaging the aorta. Screening should be done on a case-by-case basis based on the signs and symptoms of people with GCA.


Mechanism
The pathological mechanism is the result of an inflammatory cascade that is triggered by an as of yet undetermined cause resulting in in the vessel wall recruiting T cells and to form granulomatous infiltrates. These infiltrates erode the middle and inner layers of the arterial leading to conditions such as aneurysm and dissection. Activation of T helper 17 (Th17) cells involved with (IL) 6, IL-17, IL-21 and IL-23 play a critical part; specifically, Th17 activation leads to further activation of Th17 through IL-6 in a continuous, cyclic fashion. This pathway is suppressed with , and more recently it has been found that IL-6 inhibitors also play a suppressive role.


Diagnosis

Physical exam
  • Palpation of the head reveals prominent temporal arteries with or without pulsation.
  • The may be tender.
  • Decreased pulses may be found throughout the body
  • Evidence of may be noted on fundal exam.
  • may be heard over the subclavian and arteries


Laboratory tests
  • Erythrocyte sedimentation rate, an inflammatory marker, >60 mm/hour (normal 1–40 mm/hour)
  • C-reactive protein, another inflammatory marker, may be elevated
  • LFTs, liver function tests, are abnormal particularly raised ALP- alkaline phosphatase
  • may also be elevated


Biopsy
The gold standard for diagnosing temporal arteritis is , which involves removing a small part of the vessel under local anesthesia and examining it for infiltrating the tissue. However, a does not definitively rule out the diagnosis; since the are involved in a patchy pattern, there may be unaffected areas on the vessel and the biopsy might have been taken from these parts. Unilateral biopsy of a 1.5–3 cm length is 85-90% sensitive (1 cm is the minimum). Characterised as intimal hyperplasia and medial granulomatous inflammation with elastic lamina fragmentation with a CD4+ predominant T cell infiltrate, currently biopsy is only considered confirmatory for the clinical diagnosis, or one of the diagnostic criteria.


Medical imaging
Radiological examination of the temporal artery with yields a . Contrast-enhanced brain MRI and are generally negative in this disorder. Recent studies have shown that 3T MRI using super high resolution imaging and contrast injection can non-invasively diagnose this disorder with high specificity and sensitivity. Temporal artery thickening on imaging has been demonstrated to have highest positive likelihood ratios for GCA when compared with other non invasive diagnostic tests.


Early recognition
Women and men approximately 45 years old and who suffer from several complaints (at least 5 of the 16 symptoms) listed below could have giant cell arteritis.

  • Fatigue and apathy
  • Stiffness in joints and/or muscles
  • Painful jaws when chewing
  • Sensitive scalp
  • Physical malaise and/or weakness
  • Bloated arteries of the temples
  • Headaches, migraine
  • Tongue problems
  • Bleakness, depression
  • Changed eyesight
  • Poor or lack of appetite
  • Reduced eyesight, blindness
  • Unusual loss of weight
  • A temperature
  • Unusual perspiration
  • Night sweats


Treatment
GCA is considered a medical emergency due to the potential of irreversible vision loss. , typically high-dose (1 mg/kg/day), should be started as soon as the diagnosis is suspected (even before the diagnosis is confirmed by biopsy) to prevent irreversible blindness secondary to ophthalmic artery occlusion. Steroids do not prevent the diagnosis from later being confirmed by biopsy, although certain changes in the histology may be observed towards the end of the first week of treatment and are more difficult to identify after a couple of months. The dose of corticosteroids is generally slowly tapered over 12–18 months. Oral steroids are at least as effective as intravenous steroids, except in the treatment of acute visual loss where intravenous steroids appear to offer significant benefit over oral steroids. Short-term side effects of prednisone are uncommon but can include mood changes, avascular necrosis, and an increased risk of infection. Some of the side effects associated with long-term use include weight gain, diabetes mellitus, , avascular necrosis, , , cardiovascular disease, and an increased risk of infection. It is unclear whether adding a small amount of is beneficial or not as it has not been studied. Injections of may also be used. Tocilizumab is a humanized that targets the interleukin-6 receptor, which is a key involved in the progression of GCA. Tocilizumab has been found to be effective at minimizing both recurrence, and flares of GCA when used both on its own and with corticosteroids. Long term use of tocilizumab requires further investigation. Tocilizumab may increase the risk of gastrointestinal perforation and , however it does not appear that there are more risks than using corticosteroids.


Epidemiology
Giant cell arteritis typically only occurs in those over the age of 50; particularly those in their 70s. It affects about 1 in 15,000 people over the age of 50 per year. It is more common in women than in men, by a ratio of 2:1, and more common in those of Northern European descent, as well as in those residing further from the . Roughly 1 in 5 people with polymyalgia rheumatica also have giant cell arteritis.


Disease impact
Giant cell arteritis and its treatment impact on people's lives because of symptoms, adverse effects of GCs and disruption to normal life. People with GCA have previously ranked ‘losing sight in both eyes permanently’, ‘having intense or severe pain’ and ‘feeling weak, tired or exhausted’ as important quality of life domains.


Terminology
The terms "giant cell arteritis" and "temporal arteritis" are sometimes used interchangeably, because of the frequent involvement of the temporal artery. However, other large vessels such as the can be involved. Giant-cell arteritis is also known as "cranial arteritis" and "Horton's disease".
(2025). 9780721629216, Saunders Elsevier.
The name ( arteritis) reflects the type of inflammatory cell involved.


External links
Page 1 of 1
1
Page 1 of 1
1

Account

Social:
Pages:  ..   .. 
Items:  .. 

Navigation

General: Atom Feed Atom Feed  .. 
Help:  ..   .. 
Category:  ..   .. 
Media:  ..   .. 
Posts:  ..   ..   .. 

Statistics

Page:  .. 
Summary:  .. 
1 Tags
10/10 Page Rank
5 Page Refs
1s Time